Classified as a complex brain disease, SUD is treatable, according to the USA National Institute of Drug Abuse (NIDA) principles of treatment [NIDA, 2008]. Given the aforementioned multiple factors, contributing to the development of SUD, its complex presentation, and associated disease burden; treatment of SUD is rated as significantly challenging. Delivering effective SUD treatment and care requires a comprehensive response, illustrated as core services and interventions delivered, within a supportive medical, mental, health, psychological, social; which comprise of housing, transportation, and educational services in addition to vocational and employment, legal and family interventions [Ehterige, Hubbard, Anderson, Caddock Flynn 1997].
…show more content…
With the overarching objective of achieving recovery, treatment objectives are set to address patient needs that are not substance use and extend to cover co-occurring psychiatric and medical disorders.
Effective treatment requires availability and accessibility to treatment, optimal patient retention, compliance, with regular monitoring and consequently treatment adaptation [NIDA, 2008]. Treatment accessibility entails a set of elements, which include flexibility, responsiveness, cultural and individual treatment tailoring.
Treatment delivered across a spectrum of levels of care commences with an evaluation of presenting and history of physical and mental health statuses, and substance use pattern confirmed by drugs screens coupled with patient placement in the appropriate level of care [ASAMPPC-II, 2001]. Medical status screening covers both chronic, acute medical and infectious diseases. Mental health screening for psychiatric and neurocognitive conditions includes aggressive and suicidal …show more content…
Given this metabolic pathway, monitoring of BUP and liver function in patients with liver diseases may be useful. Despite that, BUP was, not studied in patients with hepatic disease; AST and ALT elevation above three times the baseline in patients were recorded with hepatitis. This finding would have particular importance in patients with non-viral hepatitis due to alcohol use, and those receiving antipsychotics or other mood stabilising agents known to affect the liver enzymes [Micromedex, 2011; Elkader and Sproule
With the overarching objective of achieving recovery, treatment objectives are set to address patient needs that are not substance use and extend to cover co-occurring psychiatric and medical disorders.
Effective treatment requires availability and accessibility to treatment, optimal patient retention, compliance, with regular monitoring and consequently treatment adaptation [NIDA, 2008]. Treatment accessibility entails a set of elements, which include flexibility, responsiveness, cultural and individual treatment tailoring.
Treatment delivered across a spectrum of levels of care commences with an evaluation of presenting and history of physical and mental health statuses, and substance use pattern confirmed by drugs screens coupled with patient placement in the appropriate level of care [ASAMPPC-II, 2001]. Medical status screening covers both chronic, acute medical and infectious diseases. Mental health screening for psychiatric and neurocognitive conditions includes aggressive and suicidal …show more content…
Given this metabolic pathway, monitoring of BUP and liver function in patients with liver diseases may be useful. Despite that, BUP was, not studied in patients with hepatic disease; AST and ALT elevation above three times the baseline in patients were recorded with hepatitis. This finding would have particular importance in patients with non-viral hepatitis due to alcohol use, and those receiving antipsychotics or other mood stabilising agents known to affect the liver enzymes [Micromedex, 2011; Elkader and Sproule